Serum cost soars 140% in a single week among FTX ‘exit pump’ fears

Serum, a “decentralized exchange” around the Solana blockchain, has performed extremely well when it comes to its SRM token cost, despite it ties towards the defunct FTX exchange.

SRM cost up 140% in a single week

Around the daily chart, the SRM/USD pair has acquired 140% within the last 7 days, hitting $.319 on November. 21 versus $.177 on November. 14.

This pressed the circulating market cap to around $73 million and “fully diluted market cap,” the market cap when the maximum supply is at circulation, to almost $2.8 billion.

SRM/USD daily cost chart. Source: TradingView

“Nearer to zero”

SRM cost rallied regardless of the ongoing delisting of Serum buying and selling pairs across major cryptocurrency exchanges, including Binance, OKEx,, and Phemex, thus raising fears a good ongoing “exit pump.”

Exit pumps are when large investors pump the token’s cost inside a low-liquidity atmosphere to draw in new buyers, simply to then dump all of their holdings on amateur investors as witnessed with plenty of pump-and-dump schemes.

Distrust in Serum is continuing to grow because of its troubling contact with FTX. Inside a November. 11 personal bankruptcy filing, a leaked balance sheet revealed that FTX had $8 billion in liabilities against a reserve mostly made up of illiquid assets, including SRM.

Particularly, FTX demonstrated about $5.4 billion price of SRM tokens in the reserves, or almost 97% of Serum’s total market cap, such as the circulating and fully-diluted supply.

Consequently, the token’s contact with FTX has elevated the potential of a significant selloff. 

“If FTX had tried to sell them in to the market during the period of per week or month or year, it might have swamped the marketplace and crashed the cost,” noted Matt Levine, Bloomberg’s Opinion Columnist, adding:

“Possibly it might have become a couple of hundred million dollars on their behalf. However I think a practical valuation of this huge stash of Serum could be nearer to zero. That isn’t a discuss Serum it’s a remark on how big the stash.”

Serum community forks to chop ties with FTX

The SRM cost rally previously 7 days coincided with efforts to distance Serum from FTX.

Serum’s key backers put how much they weigh behind an urgent situation “community fork” after wallets connected with FTX saw suspicious outflows worth $266.3 million on November. 11.

Brain Lengthy, about the most validators on Solana, noted the fork had restored the market’s sentiment in SRM.

Still, Serum’s fork has unsuccessful to draw in fresh capital toward its liquidity pools. By November. 21, the entire-value-locked inside Serum’s reserves would be a mere 33,900 SOL when compared with 3.3 million SOL at the beginning of the month.

Serum total-value-locked by November. 21. Source: Defi Llama

Serum cost collapse ahead?

Theoretically speaking, SRM stares at the potential of undergoing massive selloffs within the coming days.

The bearish argument comes from a climbing down triangular setup on its daily chart, which implies more declines ahead if along with the prior SRM cost downtrend. Climbing down Triangular patterns are trend continuation setups.

Related: Not only FTX Token: Solana cost nukes 40% as well as other ‘Sam coins’

Hence, SRM now eyes a possible breakdown underneath the triangle’s lower trendline near $.234. A effective break underneath the stated support would risk delivering the cost toward the amount in more detail comparable to the utmost distance between your triangle’s lower and upper trendline.

Quite simply, SRM cost risks crashing to $.10, or by 65%, by December 2022.

On the other hand, an outbreak over the triangle’s upper trendline near $.30 might have the token test its 50-day exponential moving average (50-day EMA the red wave) at $.56 since it’s next key upside target.

This short article doesn’t contain investment recommendations or recommendations. Every investment and buying and selling move involves risk, and readers should conduct their very own research when making the decision.

Latest stories

You might also like...